Literature DB >> 27501055

In vitro study of the antibacterial effect of the bacteriophage T5 thermostable endolysin on Escherichia coli cells.

M S Shavrina1, A A Zimin2, N V Molochkov3, S V Chernyshov1, A V Machulin2, G V Mikoulinskaia4.   

Abstract

AIMS: This study aimed to evaluate lysis of Escherichia coli stationary cell cultures induced by the combined action of bacteriophage T5 endolysin (l-alanyl-d-glutamate peptidase) and low doses of various cationic agents permeabilizing the outer membrane of Gram-negative bacteria (polymyxin B, gramicidin D, poly-l-lysine, chlorhexidine and miramistin). METHODS AND
RESULTS: The enzyme activity was assayed with the turbidimetric method. Antimicrobial activity was assessed through the number of colony-forming units (CFUs); the results of calculation were represented as logarithmic units. The optical microscopy examination of bacterial cells was conducted in the phase-contrast mode. The use of bacteriophage T5 endolysin in combination with polymyxin B (0·4 μg ml-1 ) or chlorhexidine (0·5 μg ml-1 ) made it possible to reduce the number of CFUs by five orders of magnitude; and in combination with poly-l-lysine (80 μg ml-1 ) by four orders, as compared to control. The endolysin was found to be a thermostable protein: it retained ~65% of its initial activity after heating for 30 min at 90°C. Examining the curves of its thermal denaturation revealed the half-transition temperature to be 56·3 ± 1·0°C. Circular dichroism spectra showed that after recooling the protein restored up to 80% of its native structure.
CONCLUSIONS: A substantial synergistic effect of the bacteriophage T5 endolysin and membrane-permeabilizing compounds was demonstrated. SIGNIFICANCE AND IMPACT OF THE STUDY: The study of thermal stability of the bacteriophage T5 endolysin and the quantified assessment of its antimicrobial activity have been done for the first time. The approach examined lays foundations for designing a two-component preparation which would effectively lyse cells of Gram-negative pathogens from outside.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Escherichia colizzm321990; antibacterials; endolysin; permeabilizing agents; thermal stability

Mesh:

Substances:

Year:  2016        PMID: 27501055     DOI: 10.1111/jam.13251

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  9 in total

Review 1.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 2.  Enzybiotics: Enzyme-Based Antibacterials as Therapeutics.

Authors:  Dorien Dams; Yves Briers
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Predicting Cell Wall Lytic Enzymes Using Combined Features.

Authors:  Xiao-Yang Jing; Feng-Min Li
Journal:  Front Bioeng Biotechnol       Date:  2021-01-06

4.  Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.

Authors:  Ana Catarina Duarte; Lucía Fernández; Vincent De Maesschalck; Diana Gutiérrez; Ana Belén Campelo; Yves Briers; Rob Lavigne; Ana Rodríguez; Pilar García
Journal:  NPJ Biofilms Microbiomes       Date:  2021-04-22       Impact factor: 7.290

Review 5.  Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance.

Authors:  Raymond Schuch; Cara Cassino; Xavier Vila-Farres
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

6.  Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen Escherichia coli APEC O78 and Its Endolysin Activity.

Authors:  Sangsang Deng; Qiang Xu; Yajuan Fu; Leiqin Liang; Yan Wu; Fang Peng; Meiying Gao
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

7.  Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.

Authors:  Athina Zampara; Martine C Holst Sørensen; Dennis Grimon; Fabio Antenucci; Amira Ruslanovna Vitt; Valeria Bortolaia; Yves Briers; Lone Brøndsted
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

Review 8.  Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.

Authors:  Roberto Vázquez; Ernesto García; Pedro García
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

9.  Thermophile Lytic Enzyme Fusion Proteins that Target Clostridium perfringens.

Authors:  Steven M Swift; Kevin P Reid; David M Donovan; Timothy G Ramsay
Journal:  Antibiotics (Basel)       Date:  2019-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.